PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
-4.25%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.15B
AUM Growth
+$1.15B
(-11%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
82.79%
Holding
35
New
–
Increased
1
Reduced
10
Closed
2
Top Buys
| 1 |
eHealth
EHTH
|
$22.7K |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$8.08M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$6.48M |
| 3 |
United Therapeutics
UTHR
|
$4.31M |
| 4 |
STAAR Surgical
STAA
|
$2.16M |
| 5 |
Alkermes
ALKS
|
$2.09M |
Sector Composition
| 1 | Healthcare | 98.64% |
| 2 | Financials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $171M | 14.89% | 2,061,373 -78,241 | -4% | -$6.48M |
|
|
2
United Therapeutics
UTHR
$13.8B
| $150M | 13.04% | 634,806 -18,273 | -3% | -$4.31M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $122M | 10.67% | 494,397 | – | – |
|
4
Insmed
INSM
$28.8B
| $115M | 10.04% | 5,840,398 -40,901 | -0.7% | -$807K |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $106M | 9.22% | 9,847,774 -55,987 | -0.6% | -$601K |
|
|
6
STAAR Surgical
STAA
$1.36B
| $78.5M | 6.84% | 1,106,567 -30,401 | -3% | -$2.16M |
|
7
Biogen
BIIB
$19.4B
| $73.6M | 6.42% | 360,981 | – | – |
|
|
RVNC
8
DELISTED
Revance Therapeutics, Inc.
RVNC
| $60.9M | 5.31% | 4,405,039 -10,650 | -0.2% | -$147K |
|
9
Prothena Corp
PRTA
$441M
| $45.7M | 3.98% | 1,681,477 | – | – |
|
|
SAGE
10
DELISTED
Sage Therapeutics
SAGE
| $27.5M | 2.4% | 851,409 -310 | -0% | -$10K |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $27.2M | 2.37% | 2,491,200 | – | – |
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $25.4M | 2.21% | 5,621,533 | – | – |
|
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $23.6M | 2.06% | 1,678,196 -573,638 | -25% | -$8.08M |
|
|
14
Alkermes
ALKS
$4.78B
| $18M | 1.57% | 603,400 -70,171 | -10% | -$2.09M |
|
|
15
eHealth
EHTH
$118M
| $15.4M | 1.35% | 1,654,693 +2,433 | +0.1% | +$22.7K |
|
16
Gossamer Bio
GOSS
$562M
| $14.7M | 1.28% | 1,750,651 -6,106 | -0.3% | -$51.1K |
|
17
Syndax Pharmaceuticals
SNDX
$1.41B
| $11.8M | 1.03% | 612,600 | – | – |
|
18
Align Technology
ALGN
$10.3B
| $10.5M | 0.91% | 44,305 | – | – |
|
|
EPZM
19
DELISTED
Epizyme, Inc
EPZM
| $9.96M | 0.87% | 6,774,541 | – | – |
|
20
AnaptysBio
ANAB
$569M
| $8.75M | 0.76% | 431,024 | – | – |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.05M | 0.7% | 4,473,967 | – | – |
|
|
GRTS
22
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $5.64M | 0.49% | 2,330,504 | – | – |
|
23
Kezar Life Sciences
KZR
$28.9M
| $5.43M | 0.47% | 656,200 | – | – |
|
24
Cytokinetics
CYTK
$4.23B
| $4.39M | 0.38% | 111,717 | – | – |
|
25
Travere Therapeutics
TVTX
$1.56B
| $4.02M | 0.35% | 166,069 | – | – |
|